Category: Markets
Biodexa Pharmaceuticals closes $6.0 million public offering and acquires diabetes program
From GlobeNewswire: Biodexa Pharmaceuticals PLC has announced the closing of a $6.0 million public offering, with the full exercise of
From GlobeNewswire: Biodexa Pharmaceuticals PLC has announced the closing of a $6.0 million public offering, with the full exercise of